Skip to content

Author

P. B. Mark

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Longitudinal Associations of Changes in Body Mass Index and Waist-to-Height Ratio With Cardiometabolic Risk Factors: Sex-Specific Analyses in UK Biobank.

AIMS To examine associations of within-person changes in body mass index (BMI) and waist-to-height ratio (WHtR) with cardiometabolic outcomes, characterise dose-response non-linearity and investigate effect modification by sex. MATERIALS AND METHODS In this observational UK Biobank cohort, participants had repeated a...

Ayat Musa, Mark Woodward, N. Sattar et al. · 0 citations
Open access Oct 2026

Phenotypic age acceleration is associated with higher long-term cardiovascular and mortality risk: evidence from 319,256 UK Biobank participants

Chronological age is a major risk factor for cardiovascular diseases. However, it does not capture interindividual differences in physiological ageing. Phenotypic Age is a biomarker-based measure of biological ageing. It integrates multisystem dysfunction and may better reflect cardiovascular vulnerability....

Q. Liu, M. Yang, Q. Zhang et al. · 0 citations
Open access Sep 2026

Initial Changes in eGFR during Treatment with Balcinrenone and Dapagliflozin: An Exploratory Analysis of the MIRO-CKD Trial.

INTRODUCTION The novel non-steroidal mineralocorticoid receptor antagonist balcinrenone in combination with dapagliflozin reduced urinary albumin-to-creatinine ratio (UACR) over 12 weeks in the MIRO-CKD phase 2 trial in chronic kidney disease (CKD) and induced a modest acute eGFR reduction upon treatment initiation. Th...

H. Heerspink, Erika de Sousa Amorim, Jelle M. Beernink et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.